ALPHAMAB-B(09966) announces profit expectation, expected to achieve annual profit for the first time in 2024 with profits of no less than 150 million yuan.
Kangning Jerui Pharmaceuticals - B (09966) announced that the group is expected to end on December 31, 2024...
ALPHAMAB-B (09966) announced that the group is expected to achieve a profit of no less than RMB 150 million for the year ending December 31, 2024, while it incurred a loss of approximately RMB 210.6 million for the year ending December 31, 2023. This marks the first time the company has achieved an annual profit.
The announcement stated that the company has turned a loss into a profit during the reporting period, mainly due to three authorized cooperation and sales revenue.
Related Articles

GMTEight List of A-share restricted sales and lifting restrictions | July 11th

Shenzhen Stock Exchange: JINCHUAN INTL (02362) will be removed from the list of securities eligible for trading through the Shenzhen-Hong Kong Stock Connect.

FAST RETAIL-DRS (06288) will resume trading on July 11th.
GMTEight List of A-share restricted sales and lifting restrictions | July 11th

Shenzhen Stock Exchange: JINCHUAN INTL (02362) will be removed from the list of securities eligible for trading through the Shenzhen-Hong Kong Stock Connect.

FAST RETAIL-DRS (06288) will resume trading on July 11th.
